Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Research published in the latest issue of the Journal of Medical Genetics concludes that regularly monitoring women who carry BRCA gene alterations does provide some benefits.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH will play a vital role in a new respiratory virus study.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
As a mark of respect for the funeral of Her Majesty The Queen on Monday 19 September, we are postponing our Annual Members’ Meeting, which was scheduled for this date.
File results
-
FOI/2021/0363 - Robot assisted laparascopic prostatectomy cost
-
FOI/2021/0364 - Proton Beam Therapy unit/ machine
-
FOI/2021/0377 - Stonewall diversity applications
-
FOI/2021/0431 - Data Security and Protections Toolkit
-
FOI/2021/0437 - Trust’s surgical power tool inventory
-
FOI/2021/0438 - Dermatology service costs and contract values
-
FOI/2021/0458 - Breathing filters used in mechanical ventilators for (COVID-19) patients
-
FOI/2021/0459 - Total IT budget
-
FOI/2021/0474 - Staff contacts
-
FOI/2021/0500 - Funding to charities and third sector bodies